Craecker Francoise De serves as Executive at X4 Pharmaceuticals, Inc, where they oversee executive responsibilities. Since joining the company, Craecker Francoise De has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 10, 2024 involved receiving (via award) 45,000 shares valued at $0.
Craecker Francoise De currently holds 96,667 shares of X4 Pharmaceuticals, Inc (XFOR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Craecker Francoise De has been a net neutral trader of XFOR stock. They have purchased $0 and sold $0 worth of shares.
Craecker Francoise De's most recent insider trade was on Jun 10, 2024, when they sold 45,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jun 6, 2022 | XFOR | $0 | Award | 6,667 | $N/A | Discretionary |